Addario, Bonnie http://orcid.org/0000-0002-1341-9471
Astratinei, Violeta
Binder, Louise
Geissler, Jan http://orcid.org/0000-0001-9058-5097
Horn, Marcia K. http://orcid.org/0000-0001-6505-3355
Krebs, Linda U. http://orcid.org/0000-0003-1663-3788
Lewis, Bryan http://orcid.org/0000-0002-9744-9247
Oliver, Kathy http://orcid.org/0000-0002-8317-2881
Spiegel, Andrew
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Accepted: 11 July 2023
First Online: 26 July 2023
Declarations
:
: Bristol-Myers Squibb provided financial support for assistance with the writing and editing of the manuscript by Claire Montell, Medical Writer (UK). Bristol-Myers Squibb provided a grant to ensure the paper was published with Open Access. Bristol-Myers Squibb had no role in the drafting or approval of the manuscript.
: Bonnie Addario, Violeta Astratinei, Marcia K. Horn, Linda U. Krebs, Bryan Lewis, and Andrew Spiegel have no financial or other relationships, conditions, or circumstances that present a potential or actual conflict of interest that influenced what is written in the submitted work. Louise Binder has no actual, perceived, or potential conflict of interest with regard to this paper. Save Your Skin Foundation, for which she is the health policy consultant accepts educational and non-directed grants for its work from a number of pharmaceutical companies and grants for specific projects for which it has sought support. Save Your Skin Foundation also accepts a small number of donations from the general public and on occasion it has been supported by bequests. In her role for Save Your Skin Foundation, she has occasionally accepted honoraria for speaking engagements and the provision of advice on specific policy issues for select pharmaceutical companies. Jan Geissler has no actual, perceived or potential conflicts of interests with regard to this publication. Over the past 3 years, he has performed advisory roles and consultancy on meaningful patient engagement to a number of pharmaceutical companies. He has also received contributions from IMI-funded consortium projects HARMONY, HARMONY-PLUS, and EUPATI by EFPIA member companies. Kathy Oliver has no actual, perceived, or potential conflicts of interest with regard to this paper. However, for the sake of transparency, she confirms that the International Brain Tumour Alliance, of which she is the Chair and Co-Director, accepts educational and non-directed grants for its work from a number of pharmaceutical and medical device companies. The International Brain Tumour Alliance also accepts a small number of donations from the general public and on occasion it has been supported by private trusts/bequests. For further details of the International Brain Tumour Alliance’s funders, please visit ExternalRef removed.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no new data were created or analyzed in this study.
: Not applicable.
: All authors contributed to the conceptualization, drafting, and review of this article. All authors read and approved the final version.